Summary
CME Group Inc. (CME) filed an 8-K on October 26, 2005, to report a material modification to the rights of its security holders. The company's Board of Directors approved a Second Amendment to its Rights Agreement, primarily increasing the "Purchase Price" for exercising a "Right" from $105 to $1,000. This adjustment was deemed necessary due to the significant increase in CME's Class A common stock value, which rose from its IPO price of $35.00 to $348.00 per share shortly before the amendment. The Board stated the amendment is intended to continue protecting stockholders from coercive or unfair takeover attempts. The company emphasized that the Rights Agreement, which includes anti-takeover provisions designed to cause dilution to hostile acquirers, is not in response to any current specific takeover threat. The rights are redeemable under certain conditions and can be amended to permit board-approved transactions. The amendment itself does not alter the fundamental purpose of the Rights Agreement in safeguarding shareholder value.
Key Highlights
- 1CME Group Inc. amended its Rights Agreement to increase the exercise price of its "Rights" from $105 to $1,000 per "Unit".
- 2This increase in the purchase price is a direct response to the substantial appreciation of CME's Class A common stock, which traded at $348.00 per share following its IPO.
- 3The primary stated purpose of the Rights Agreement and its amendment is to protect stockholders from coercive or unfair takeover bids.
- 4The amendment is not prompted by any specific known takeover attempt or threat.
- 5The Rights Agreement contains anti-takeover provisions that can dilute the stake of an acquirer attempting to gain control without board approval.
- 6The company retains the right to redeem the Rights under specific conditions prior to a triggering event (e.g., a 15% ownership threshold being crossed).
- 7The Rights will continue to trade with the Class A common stock unless separated upon the occurrence of certain future events.